主持人

CLAIRE ZILLMAN

Senior Editor, FORTUNE Asia

Claire Zillman is a Hong Kong-based senior editor for Fortune, where she oversees a team of reporters that covers business in Asia.She also writes stories on women in business and gender in the workplace.Her feature on the then -unbroken glass ceiling at Wall Street’s banking giants won a New York Press Award for business reporting.She co- authors Fortune’s Broadsheet newsletter about women in business and co-chairs various Most Powerful Women conferences.Before moving to Hong Kong in 2020, she worked for Fortune in London and New York.Earlier in her career, Claire was a reporter for The American Lawyer magazine, covering legal affairs.She graduated with degrees in journalism and history from Syracuse University and is originally from Chicago.

Siyuan Chen

Vice President, General Manager of Bristol Myers Squibb for China & Asia Cluster, President of China

Ms. Siyuan Chen has been Vice President, General Manager of Bristol Myers Squibb for China & Asia Cluster, President of China since January 2023, to take on responsibilities to oversee Mainland China, Hong Kong, Taiwan, Korea and Southeast Asia markets. Siyuan is a true leader, full of passion for people and patients. Since joining Bristol Myers Squibb as the President & General Manger for China in December 2019, Siyuan has demonstrated strong leadership which was pivotal in strengthening the local talents and organization in China. In 2020, Siyuan has led Bristol Myers Squibb China team to successfully formulate and launch the “China 2030 Strategy” and achieved a series of impressive milestones. As a leader committed to shaping the industry environment in China, Siyuan is currently the Vice Chairman of the 6th Council of the China Association of Enterprises with Foreign Investment (CAEFI), a member of the 2022-2023 Executive Committee of CAEFI’s R&D-based Pharmaceutical Association Committee (RDPAC), and the Vice Chairman of the China Association of Pharmaceutical Commerce (CAPC). Prior to Bristol Myers Squibb, Siyuan held several senior management roles at GlaxoSmithKline and Novartis. She also worked for the Boston Consulting Group as a consultant. Siyuan received a Bachelor of Science in Biochemistry from Fudan University, an MBA degree from the Columbia Business School, and a Master of Science in Computer Science from the University of Massachusetts.

ALEX GU

SENIOR VICE PRESIDENT AND PRESIDENT OF MEDTRONIC GREATER CHINA

Alex Gu serves as Senior Vice President and President of Medtronic Greater China. Based in Shanghai, he is a member of Medtronic Executive Committee since January 2018. Previously Alex held the role of Vice president of Regional Growth Initiatives and was business leader for Greater China Minimally Invasive Therapies Group (MITG). He joined Medtronic in 2015 upon the close of the Covidien acquisition. At Covidien, he was President of China region and had overseen all the businesses and functions since 2009. Before Covidien, Alex was in various leadership positions at McKinsey & Company, General Electric, and Sabic, both in the United States and China. He started his career as a member of the GE Edison Leadership Program (ELP), then served several roles with increasing responsibilities within GE Healthcare in the U.S. As one of AdvaMed China Council's founding members, Alex was elected Chairman of the AdvaMed China Board in January 2023. He holds the role of Independent Non-Executive Director of a Hong Kong-listed pharmaceutical company. Alex's contributions to healthcare industry earned him the prestigious Shanghai Magnolia Award in 2021. The 14th Health China Forum named him one of the Top 10 Healthcare Leaders in 2022. Alex holds an MBA from the University of Chicago's Booth School of Business. He is a Fellow of the Aspen Institute China Fellowship Program and a member of the Aspen Global Leadership Network.

CHUN WU

MANAGING DIRECTOR & SENIOR PARTNER MANAGING PARTNER OF GREATER CHINA, BCG

Dr. Chun Wu is the Managing Partner of BCG Greater China, leading the business in this region. Since 2021, she has led BCG's expert team in Greater China to provide consulting service for hundreds of leading multinational companies and large local Chinese enterprises, help clients tailor solutions to meet their business objectives, empower organizational growth, and actively drive corporate transformation and sustainability. Dr. Chun Wu is also a senior expert in healthcare industry. She has served various multinational and local healthcare clients on strategic and operational topics, covering healthcare reform impact and growth strategy; R&D, especially new technology platforms; go- to-market and business excellence; commercial excellence and digital transformation; and organization change. In addition, Dr. Wu Chun is a frequent guest speaker at various top business forums. Recently, she has been invited to attend high-end forums and conferences such as the China Development Forum, Boao Forum for Asia, Summer Davos, Fortune Global 500 Summit, and World Artificial Intelligence Conference, leading industry trends on cutting-edge topics such as business innovation, digital economy, and sustainable development. Dr. Chun Wu holds a bachelor's degree in Biochemistry from Peking University and a PhD in genetics from Yale University.

Li Zhong

Asia Pacific President, Walgreens Boots Alliance

Mr. Li Zhong has extensive international experience in the healthcare, retail, and consumer goods sectors. He has held senior positions in leading companies across the UK, Europe, Asia, and the US, with responsibilities spanning business operations, corporate finance, M&A, integration and fund management.

 

Mr. Zhong joined Walgreens Boots Alliance (WBA) in 2008. Since 2021, he has served as President of Asia Pacific, responsible for WBA’s operations, joint ventures, equity and fund investment businesses across the region. He is currently Vice Chairman of Guoda Drugstore (China's leading pharmacy chain with about 10,000 stores), and a Standing Committee Member of the China Association of Pharmaceutical Commerce (China’s industry body for pharmaceutical distribution and retail pharmacy).

 

Prior to his current role, Mr. Zhong was WBA Group Vice President of Global M&A and Development at its global headquarters in Chicago, where he played a key role in driving the Group’s strategic deals focusing on healthcare services and digital innovations, including the oversight of WBA's corporate venture capital arm (Well Ventures) and various fund investments.

 

Mr. Zhong’s previous boardroom experience includes serving on the boards of several pharmaceutical services and healthcare technology companies in the US, Europe and China.

 

Before joining WBA, he held several management roles at Procter & Gamble UK/Europe.

 

Mr. Zhong earned his Master’s and Bachelor’s degrees in Mathematics with Computer Science from the University of Cambridge. He is a Fellow of The Chartered Institute of Management Accountants.